Buprenorphine and Naloxone Sublingual Film (Suboxone) and Sodium oxybate
Determining the interaction of Buprenorphine and Naloxone Sublingual Film (Suboxone) and Sodium oxybate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: The central nervous system and respiratory depressant effects of sodium oxybate, which is the sodium salt of gamma hydroxybutyrate (GHB), may be potentiated by concomitant use of other agents with CNS depressant effects. An increased risk of serious adverse reactions such as respiratory depression, hypotension, profound sedation, syncope, coma, and even death should be considered. MANAGEMENT: Concomitant use of sodium oxybate with other CNS depressants should be avoided whenever possible. Otherwise, close monitoring and/or dosage reductions should be considered. If short-term use of a CNS depressant is required (e.g., post- or perioperative opioid), a temporary interruption of sodium oxybate therapy may be appropriate. All patients treated with sodium oxybate should be advised not to drive, operate machinery, or engage in hazardous activities requiring mental alertness and motor coordination for at least 6 hours after taking the second nightly dose of sodium oxybate and until they know how the medication affects them. References Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 "Product Information. Xyrem (sodium oxybate)." Orphan Medical, Minnetonka, MN.
Professional:GENERALLY AVOID: The central nervous system and respiratory depressant effects of sodium oxybate, which is the sodium salt of gamma hydroxybutyrate (GHB), may be potentiated by concomitant use of other agents with CNS depressant effects. An increased risk of serious adverse reactions such as respiratory depression, hypotension, profound sedation, syncope, coma, and even death should be considered.
MANAGEMENT: Concomitant use of sodium oxybate with other CNS depressants should be avoided whenever possible. Otherwise, close monitoring and/or dosage reductions should be considered. If short-term use of a CNS depressant is required (e.g., post- or perioperative opioid), a temporary interruption of sodium oxybate therapy may be appropriate. All patients treated with sodium oxybate should be advised not to drive, operate machinery, or engage in hazardous activities requiring mental alertness and motor coordination for at least 6 hours after taking the second nightly dose of sodium oxybate and until they know how the medication affects them.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Xyrem (sodium oxybate)." Orphan Medical, Minnetonka, MN.
Generic Name: buprenorphine / naloxone
Brand name: Bunavail, Suboxone, Zubsolv
Synonyms: Buprenorphine and naloxone (oral/sublingual), Buprenorphine and Naloxone
Generic Name: sodium oxybate
Brand name: Xyrem
Synonyms: Sodium Oxybate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine and Naloxone Sublingual Film (Suboxone)-Sodium phenylacetate and benzoate Intravenous
- Buprenorphine and Naloxone Sublingual Film (Suboxone)-Sodium Phenylacetate and Sodium Benzoate
- Buprenorphine and Naloxone Sublingual Film (Suboxone)-Sodium Phenylacetate and Sodium Benzoate Injection
- Buprenorphine and Naloxone Sublingual Film (Suboxone)-Sodium phenylbutyrate
- Buprenorphine and Naloxone Sublingual Film (Suboxone)-Sodium Phenylbutyrate Powder
- Buprenorphine and Naloxone Sublingual Film (Suboxone)-Sodium Phenylbutyrate Tablets
- Sodium oxybate-Buprenorphine and Naloxone Sublingual Tablets
- Sodium oxybate-Buprenorphine Buccal Film
- Sodium oxybate-Buprenorphine Extended-Release Injection
- Sodium oxybate-Buprenorphine implant
- Sodium oxybate-Buprenorphine Injection
- Sodium oxybate-Buprenorphine injection - Buprenex